BRPI0812426A2 - Composição, uso da composição, métodos para o tratamento de distúrbio ósseo degenerativo, e de psoríase, suplemento dietético ou um alimento funcional, método para suplementar ou aumentar níveis de hidroxiprolina em um indivíduo - Google Patents

Composição, uso da composição, métodos para o tratamento de distúrbio ósseo degenerativo, e de psoríase, suplemento dietético ou um alimento funcional, método para suplementar ou aumentar níveis de hidroxiprolina em um indivíduo

Info

Publication number
BRPI0812426A2
BRPI0812426A2 BRPI0812426-4A2A BRPI0812426A BRPI0812426A2 BR PI0812426 A2 BRPI0812426 A2 BR PI0812426A2 BR PI0812426 A BRPI0812426 A BR PI0812426A BR PI0812426 A2 BRPI0812426 A2 BR PI0812426A2
Authority
BR
Brazil
Prior art keywords
composition
disturbus
supplementing
psoriasis
increasing
Prior art date
Application number
BRPI0812426-4A2A
Other languages
English (en)
Inventor
Anders Aksnes
Original Assignee
Bergen Teknologioverforing As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bergen Teknologioverforing As filed Critical Bergen Teknologioverforing As
Publication of BRPI0812426A2 publication Critical patent/BRPI0812426A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
BRPI0812426-4A2A 2007-06-08 2008-06-06 Composição, uso da composição, métodos para o tratamento de distúrbio ósseo degenerativo, e de psoríase, suplemento dietético ou um alimento funcional, método para suplementar ou aumentar níveis de hidroxiprolina em um indivíduo BRPI0812426A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93373707P 2007-06-08 2007-06-08
DKPA200700833 2007-06-08
PCT/EP2008/057084 WO2008148873A2 (en) 2007-06-08 2008-06-06 Hydroxyproline compositions and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0812426A2 true BRPI0812426A2 (pt) 2014-12-02

Family

ID=39743735

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812426-4A2A BRPI0812426A2 (pt) 2007-06-08 2008-06-06 Composição, uso da composição, métodos para o tratamento de distúrbio ósseo degenerativo, e de psoríase, suplemento dietético ou um alimento funcional, método para suplementar ou aumentar níveis de hidroxiprolina em um indivíduo

Country Status (7)

Country Link
US (1) US20120004157A1 (pt)
EP (1) EP2167076A2 (pt)
CN (1) CN101795685A (pt)
BR (1) BRPI0812426A2 (pt)
CA (1) CA2726848A1 (pt)
CL (1) CL2008001640A1 (pt)
WO (1) WO2008148873A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
WO2010146078A2 (en) 2009-06-16 2010-12-23 Bergen Teknologioverføring As Novel uses of hydroxyproline compositions
NO339201B1 (no) * 2009-06-25 2016-11-14 Trouw Int Bv Fiskefôr med en vannløselig antioksidant og karotenoidpigment og fremgangsmåte for å øke retensjonen av pigmentet i fiskekjøtt
US20120183668A1 (en) * 2010-08-11 2012-07-19 E.I. Du Pont De Nemours And Company Aquaculture feed compositions
EP2603094A1 (en) * 2010-08-11 2013-06-19 E.I. Du Pont De Nemours And Company A sustainable aquaculture feeding strategy
CA2794639C (en) * 2011-11-01 2019-09-17 Ryan W. Schoor Crustacean bait
RU2607604C2 (ru) * 2012-11-15 2017-01-10 Хилл'С Пет Ньютришн, Инк. Профилактика образования безоаров путем ограничения содержания минеральных веществ в рационе
JP6064573B2 (ja) * 2012-12-12 2017-01-25 栗田工業株式会社 飼料用添加物及び混合飼料
US20150181909A1 (en) * 2013-12-26 2015-07-02 Algal Scientific Corporation Method for improving feed efficiency and increasing growth rates in animals
US20150182485A1 (en) * 2013-12-30 2015-07-02 Benemilk Oy Fish feed, methods for preparing feed, and feeding fish
TR201908203T4 (tr) * 2014-09-23 2019-06-21 Europharma As Bir balık yemi ve bunun salmonidae deki alabalıkgiller hemorajik smolt sendromunun (HSS) profilaksisinde ve tedavisinde kullanımı.
CA2958439C (en) * 2014-10-02 2022-09-20 Evonik Industries Ag Feedstuff of high abrasion resistance and good stability in water, containing pufas
ES2870093T3 (es) 2014-10-02 2021-10-26 Evonik Operations Gmbh Biomasa que contiene PUFA con estabilidad celular elevada y su empleo para la producción de piensos
FI3200604T4 (fi) 2014-10-02 2025-07-29 Evonik Operations Gmbh Menetelmä rehun valmistamiseksi
EP3310189A4 (en) * 2015-05-20 2019-03-13 Indiana Soybean Alliance Inc. PROCESS FOR INCREASING THE USE OF SOY PROTEIN BY SALMON FISH
US10379933B2 (en) * 2017-02-15 2019-08-13 Sap Se Sensor data anomaly detection
US11382885B2 (en) 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
CN107602685B (zh) * 2017-11-03 2020-09-15 宁波大学 一种从银鲳中分离的具有抗菌性能的多肽
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms
JPWO2021015040A1 (pt) * 2019-07-25 2021-01-28
CN112914006B (zh) * 2021-03-09 2022-01-25 天津渤化讯创科技有限公司 一种羟脯氨酸与鹰嘴豆复合蛋白肽固体饮料及其生产方法
CN113016670B (zh) * 2021-03-30 2023-02-03 海南省海洋与渔业科学院 一种罗非鱼咸水养殖方法
CN113647345B (zh) * 2021-07-30 2023-01-03 陵水晨海种业有限公司 一种金鼓鱼工厂化人工育苗方法
CN113480366A (zh) * 2021-08-20 2021-10-08 山东得和明兴生物科技有限公司 一种微生物液体菌肥
US12059430B2 (en) 2022-09-29 2024-08-13 Adora Animal Health Corporation Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617626A1 (en) * 1991-12-18 1994-10-05 Pfizer Inc. Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation
AU2698997A (en) * 1996-04-16 1997-11-07 Chephasaar Chem.-Pharm. Fabrik Gmbh Agent for inhibiting leukocyte invasion of tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
DE19855426A1 (de) * 1998-12-02 2000-06-08 Wolfgang Langhoff Mittel zur Therapie und Prophylaxe von rheumatisch-arthritischen Erkrankungen und zur Prophylaxe von cardiovaskulären Erkrankungen
JP2001231461A (ja) * 2000-02-28 2001-08-28 San Baiorekkusu:Kk 魚介類用飼料添加剤およびこれを含む魚介類用飼料
CN1423528A (zh) * 2000-04-18 2003-06-11 雀巢制品公司 营养单元
EP1301193A4 (en) * 2000-07-19 2006-04-05 Biodix Co Ltd METHOD OF MANUFACTURING AND COMPOUNDS CONTAINING A MEDICAL EXTRACT OF PLANT INCLUDING PROPHYLAXIS AND TREATMENT OF ARTHRITIS
CA2441948A1 (en) * 2001-02-05 2002-08-15 Jallal Messadek Glycine betaine and its use as anti-hemorrhagic agent
US7223437B2 (en) * 2001-12-14 2007-05-29 Archer Daniels Midland Company Pressure molded proteinaceous wafers, ingredient inclusions, cookies, and waffle food products; pressure molding process method, mass balanced and viscosity specific batter for the manufacture of these food products, and final proteinaceous food products derived ut
WO2003075903A2 (en) * 2002-03-08 2003-09-18 Universiteit Leiden Use proline and its functional equivalentsfor quenching ros and/ or radicals
JP4115361B2 (ja) * 2003-08-13 2008-07-09 株式会社Ｐｈｇ 食用組成物
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US20070293559A1 (en) * 2004-09-21 2007-12-20 Erika Kagami Orally Administered Agent For Preventing Or Improving Dry Station Of Skin
FR2879443B1 (fr) * 2004-12-21 2007-07-13 Jean Noel Thorel Utilisation d'une base nutritive complexe dans le domaine cosmetique, en particulier capillaire
US20070059342A1 (en) * 2005-09-13 2007-03-15 Johns William C Method and palatable pharmaceutical composition for treating herpes in animals
GB0522045D0 (en) * 2005-10-28 2005-12-07 Novartis Ag Pharmaceutical compositions
US20070190130A1 (en) * 2006-02-16 2007-08-16 Mark William A Protein hydrolysate excipients
ITTO20060282A1 (it) * 2006-04-14 2007-10-15 Univ Degli Studi Torino Mezzo di coltura e composizione farmaceutica per la rigenerazione del tessuto cartilagineo relativo procedimento relativi usi e prodotti

Also Published As

Publication number Publication date
CL2008001640A1 (es) 2008-11-07
US20120004157A1 (en) 2012-01-05
CN101795685A (zh) 2010-08-04
WO2008148873A2 (en) 2008-12-11
WO2008148873A3 (en) 2009-08-20
EP2167076A2 (en) 2010-03-31
CA2726848A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
BRPI0812426A2 (pt) Composição, uso da composição, métodos para o tratamento de distúrbio ósseo degenerativo, e de psoríase, suplemento dietético ou um alimento funcional, método para suplementar ou aumentar níveis de hidroxiprolina em um indivíduo
BRPI0810956A2 (pt) "composição, método para controlar de modo preventivo ou curativo e uso da composição"
DK2344148T3 (da) Ernæringstilskud til forebyggelse eller moderering af knoglemarvsparalyse eller neutropæni under anti-cancerbehandling
BR112012008854A2 (pt) combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
BRPI0812774A2 (pt) Suplementos alimentares para promoção de crescimento, reparo e manutenção de osso e juntas
WO2010075547A9 (en) Methods and systems for fat reduction and/or cellulite treatment
BRPI0908503A2 (pt) partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
WO2008130989A3 (en) Prosthetic implants
WO2010132502A3 (en) Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
BRPI0816097A2 (pt) composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
BRPI0905733A2 (pt) "composição, formulação farmacêutica, método para tratamento de câncer positivo para her2 e método pára a produção de uma composição farmacêutica"
BRPI1009381A2 (pt) compostos, composição farmacêutica, método para tratar doença ou condição associada com função de trap1 em sujeito em necessidade do mesmo e uso de compostos e composição farmacêutica
ZA201001189B (en) Treatments using vitamin k analogues and derivatives
BRPI0811059A2 (pt) combinação, composição farmacêutica, método para tratar câncer em um animal de sangue quente, e, uso de uma combinação
BRPI0911203A2 (pt) peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
BRPI0716985A2 (pt) Composição nutricional, uso da mesma, e, suplemento nutricional para o tratamento de pacientes que sofrem de alergias a alimentos
BRPI0910963A2 (pt) composição imunogênica, método para tratar ou prevenir doença pneumocócica, e , uso de uma composição imunogênica
BRPI0714474A2 (pt) "aditivo alimentar, gênero alimenticio fortificado com fibras, método para fortificar um gênero alimenticio com fibras e bebida forticada com fibra"
BRPI0917949A2 (pt) Gordura de óleo, composição de gordura ou óleo, composição alimentícia, e, método para fornecer um ou mais benefícios à saúde
BRPI0818323A2 (pt) composição farmacêutica, uso de uma composição farmacêutica, e, método para tratar câncer.
EP2155705A4 (en) COMPOSITIONS FOR REGULATING OR MODULATING QUORUM DETECTION IN BACTERIA, METHODS OF USING THE SAME, AND METHODS OF REGULATING AND MODULATING QUORUM DETECTION IN BACTERIUM
BRPI0816952A2 (pt) Composição para tratar ou contralar uma infecção em um indivíduo, e, usos de uma fluoroquinolona e de uma combinação
BRPI0807730A2 (pt) Método de condicionamento de tecidos e composição sólida para tratamento de tecidos
BRPI0719089A2 (pt) Método de tratamento de tecido e composição para transmitir hidrofobicidade diferencial
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/401 (2006.01), A23K 20/142 (2016.01), A23K